Methyl 4-bromo-1H-pyrrolo[2,3-c]pyridine-2-carboxylate, 95.0%, 10g

Triethylamine, min. 99.5%, for synthesis, 100 ml, glass packaging

Methyl 3-bromoimidazo[1,5-a]pyridine-1-carboxylate, 95.0%, 250mg

2-(2-BROMO-5-(TRIFLUOROMETHYL)PHENYL)ACETIC ACID, 95.0%, 5g

anti-Desmoglein 1/2 mouse monoclonal, DG 3.10, 0.2 ml

Fmoc-(S)-3-Amino-4-(3,4-dichloro-phenyl)-butyric acid, 97%, 1g

NEOPENTYL GLYCOL DIBENZOATE, 95%, 25g

(S)-Methyl 2-((tert-butoxycarbonyl)amino)-4-hydroxybutanoate, 95.0%, 100mg

6-Chloro-1H-indole-2-carboxamide, 97%, 1g

N-(2-Bromo-ethyl)-4-fluoro-benzenesulfonamide, 95.0%, 5g

6-Cyclopropyl-1-isopropyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid, 95.0%, 500mg

(1H-Benzoimidazol-2-yl)-acetic acid, 95.0%, 25g